SU5416 attenuated lipopolysaccharide-induced acute lung injury in mice by modulating properties of vascular endothelial cells

References

• Yingkun N, Zhenyu W, Jing L, Xiuyun L, Huimin Y. Stevioside protects LPS-induced acute lung injury in mice. Inflammation. 2013;36(1):242–250. doi:10.1007/s10753-012-9579-622968433
   PubMed Web of Science ®Google Scholar
• Dengler V, Downey GP, Tuder RM, Eltzschig HK, Schmidt EP. Neutrophil intercellular communication in acute lung injury. Emerging roles of microparticles and gap junctions. Am J Respir Cell Mol Biol. 2013;49(1):1–5. doi:10.1165/rcmb.2012-0374OC23815257
   PubMed Web of Science ®Google Scholar
• Kosutova P, Mikolka P, Balentova S, et al. Intravenous DXM attenuated inflammation and influenced apoptosis of lung cells in an experimental model of acute lung injury. Physiol Res. 2016;65(Supplementum 5):S663–S672.28006948
   PubMed Web of Science ®Google Scholar
• Aujla SJ, Chan YR, Zheng M, et al. IL-22 mediates mucosal host defense against gram-negative bacterial pneumonia. Nat Med. 2008;14(3):275–281. doi:10.1038/nm171018264110
   PubMed Web of Science ®Google Scholar
• Kim KY, Lee HS, Seol GH. Eucalyptol suppresses matrix metalloproteinase-9 expression through an extracellular signal-regulated kinase-dependent nuclear factor-kappa B pathway to exert anti-inflammatory effects in an acute lung inflammation model. J Pharm Pharmacol. 2015;67(8):1066–1074. doi:10.1111/jphp.1237125773735
   PubMed Web of Science ®Google Scholar
• Rice P, Martin E, He J-R, et al. Febrile-range hyperthermia augments neutrophil accumulation and enhances lung injury in experimental gram-negative bacterial pneumonia. J Immunol. 2005;174(6):3676–3685.15749906
   PubMed Web of Science ®Google Scholar
• Chen G, Sun X, Dong C. RhoA regulates lipopolysaccharide‑induced lung cell injury via the Wnt/β‑catenin pathway. Mol Med Rep. 2017;16(6):8501–8506. doi:10.3892/mmr.2017.766228990085
   PubMed Web of Science ®Google Scholar
• Ding Q, Liu G, Zeng Y, et al. Glycogen synthase kinase‑3β inhibitor reduces LPS‑induced acute lung injury in mice. Mol Med Rep. 2017;16(5):6715–6721. doi:10.3892/mmr.2017.746928901469
   PubMed Web of Science ®Google Scholar
• Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998;282(5396):2085–2088. doi:10.1126/science.282.5396.20859851930
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med. 2007;13(11):460–469. doi:10.1016/j.molmed.2007.09.00218029230
   PubMed Web of Science ®Google Scholar
• Vaure C, Liu Y. A comparative review of toll-like receptor 4 expression and functionality in different animal species. Front Immunol. 2014;5:316. doi:10.3389/fimmu.2014.0031625071777
   PubMed Web of Science ®Google Scholar
• Broad A, Kirby JA, Jones DE. Applied immunology and transplantation research group: toll-like receptor interactions: tolerance of MyD88-dependent cytokines but enhancement of MyD88-independent interferon-beta production. Immunology. 2007;120(1):103–111. doi:10.1111/j.1365-2567.2006.02485.x17034424
   PubMed Web of Science ®Google Scholar
• Hoth JJ, Wells JD, Brownlee NA, et al. Toll-like receptor 4-dependent responses to lung injury in a murine model of pulmonary contusion. Shock. 2009;31(4):376–381. doi:10.1097/SHK.0b013e318186227918665044
   PubMed Web of Science ®Google Scholar
• Villar J, Cabrera N, Casula M, et al. Mechanical ventilation modulates Toll-like receptor signaling pathway in a sepsis-induced lung injury model. Intensive Care Med. 2010;36(6):1049–1057. doi:10.1007/s00134-010-1799-320397011
   PubMed Web of Science ®Google Scholar
• Liu W, Shan L-P, Dong X-S, Liu Z. Toll-like receptor 4 implicated in acute lung injury induced by paraquat poisoning in mice. Int J Clin Exp Med. 2014;7(10):3392–3397.25419373
   PubMed Web of Science ®Google Scholar
• Joh E-H, Gu W, Kim D-H. Echinocystic acid ameliorates lung inflammation in mice and alveolar macrophages by inhibiting the binding of LPS to TLR4 in NF-κB and MAPK pathways. Biochemical Pharmacology. 2012;84(3):331–340. doi:10.1016/j.bcp.2012.04.02022564908
   PubMed Web of Science ®Google Scholar
• Al-Harbi NO, Imam F, Al-Harbi MM, et al. DXM attenuates LPS-induced acute lung injury through inhibition of NF-κB, COX-2, and pro-inflammatory mediators. Immunol Invest. 2016;45(4):349–369. doi:10.3109/08820139.2016.115781427104958
   PubMed Web of Science ®Google Scholar
• Papaioannou AI, Kostikas K, Kollia P, Gourgoulianis KI. Clinical implications for vascular endothelial growth factor in the lung: friend or foe? Respir Res. 2006;7:128. doi:10.1186/1465-9921-7-12817044926
   PubMed Web of Science ®Google Scholar
• Mura M, Santos Dos CC, Stewart D, Liu M. Vascular endothelial growth factor and related molecules in acute lung injury. J Appl Physiol. 2004;97(5):1605–1617. doi:10.1152/japplphysiol.00202.200415475552
   PubMed Web of Science ®Google Scholar
• Kaner RJ, Crystal RG. Compartmentalization of vascular endothelial growth factor to the epithelial surface of the human lung. Mol Med. 2001;7(4):240–246. doi:10.1007/BF0340184311471568
   PubMed Web of Science ®Google Scholar
• Fujita N, Imai J-I, Suzuki T, et al. Vascular endothelial growth factor-A is a survival factor for nucleus pulposus cells in the intervertebral disc. Biochem Biophys Res Commun. 2008;372(2):367–372. doi:10.1016/j.bbrc.2008.05.04418492486
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lu Y, Ma L, et al. Activation of vascular endothelial growth factor receptor-3 in macrophages restrains TLR4-NF-κB signaling and protects against endotoxin shock. Immunity. 2014;40(4):501–514. doi:10.1016/j.immuni.2014.01.01324656836
   PubMed Web of Science ®Google Scholar
• Takyar S, Zhang Y, Haslip M, et al. An endothelial TLR4-VEGFR2 pathway mediates lung protection against oxidant-induced injury. FASEB J. 2016;30(3):1317–1327. doi:10.1096/fj.15-27502426655705
   PubMed Web of Science ®Google Scholar
• Litz J, Sakuntala Warshamana-Greene G, Sulanke G, Lipson KE, Krystal GW. The multi-targeted kinase inhibitor SU5416 inhibits small cell lung cancer growth and angiogenesis, in part by blocking kit-mediated VEGF expression. Lung Cancer. 2004;46(3):283–291. doi:10.1016/j.lungcan.2004.05.00515541812
   PubMed Web of Science ®Google Scholar
• Yu X, Lin Q, Qin X, et al. ACE2 antagonizes VEGFa to reduce vascular permeability during acute lung injury. Cell Physiol Biochem. 2016;38(3):1055–1062. doi:10.1159/00044555126938051
   PubMedGoogle Scholar
• Takao Y, Mikawa K, Nishina K, Maekawa N, Obara H. Lidocaine attenuates hyperoxic lung injury in rabbits. Acta Anaesthesiol Scand. 1996;40(3):318–325.8721462
   PubMed Web of Science ®Google Scholar
• Vlaar APJ, Juffermans NP. Transfusion-related: a clinical review. Lancet. 2013;382(9896):984–994. doi:10.1016/S0140-6736(12)62197-723642914
   PubMed Web of Science ®Google Scholar
• Jernigan NL, Naik JS, Weise-Cross L, et al. Contribution of reactive oxygen species to the pathogenesis of pulmonary arterial hypertension. PLoS One. 2017;12(6):e0180455. doi:10.1371/journal.pone.018045528666030
   PubMed Web of Science ®Google Scholar
• Kim EH, Kim M-S, Jeong YK, et al. Mechanisms for SU5416 as a radiosensitizer of endothelial cells. Int J Oncol. 2015;47(4):1440–1450. doi:10.3892/ijo.2015.312726314590
   PubMed Web of Science ®Google Scholar
• Ou XM, Li WC, Liu DS, et al. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice. Int Immunopharmacol. 2009;9(1):70–79. doi:10.1016/j.intimp.2008.10.00218976720
   PubMed Web of Science ®Google Scholar
• Chen XY, Dou YX, Luo DD, et al. β-Patchoulene from patchouli oil protects against LPS-induced acute lung injury via suppressing NF-κB and activating Nrf2 pathways. Int Immunopharmacol. 2017;50:270–278. doi:10.1016/j.intimp.2017.07.00128711783
   PubMed Web of Science ®Google Scholar
• Liu XJ, Zhang ZD, Ma XC. High glucose enhances LPS-stimulated human PMVEC hyperpermeability via the NO pathway. Exp Ther Med. 2013;6(2):361–367. doi:10.3892/etm.2013.114524137189
   PubMed Web of Science ®Google Scholar
• Akaike T, Maeda H. Nitric oxide and virus infection. Immunology. 2000;101(3):300–308.11106932
   PubMed Web of Science ®Google Scholar
• van der Vliet A, Eiserich JP, Shigenaga MK, Cross CE. Reactive nitrogen species and tyrosine nitration in the respiratory tract: epiphenomena or a pathobiologic mechanism of disease? Am J Respir Crit Care Med. 1999;160(1):1–9. doi:10.1164/ajrccm.160.1.980704410390372
   PubMed Web of Science ®Google Scholar
• He X, Qian Y, Li Z, et al. TLR4-upregulated IL-1β and IL-1RI promote alveolar macrophage pyroptosis and lung inflammation through an autocrine mechanism. Sci Rep. 2016;6:31663. doi:10.1038/srep3166327526865
   PubMed Web of Science ®Google Scholar
• Deng G, He H, Chen Z, et al. Lianqinjiedu decoction attenuates LPS-induced inflammation and acute lung injury in rats via TLR4/NF-κB pathway. Biomed Pharmacother. 2017;96:148–152. doi:10.1016/j.biopha.2017.09.09428972887
   PubMed Web of Science ®Google Scholar
• Tao L, Cao F, Xu G, Xie H, Zhang M, Zhang C. Mogroside IIIE attenuates LPS-induced acute lung injury in mice partly through regulation of the TLR4/MAPK/NF-κB axis via AMPK activation. Phytother Res. 2017;31(7):1097–1106. doi:10.1002/ptr.v31.728512854
   PubMed Web of Science ®Google Scholar
• Zhao D, Zhang J, Xu G, Wang Q. Artesunate protects LPS-induced acute lung injury by inhibiting TLR4 expression and inducing Nrf2 activation. Inflammation. 2017;40(3):798–805. doi:10.1007/s10753-017-0524-628315999
   PubMed Web of Science ®Google Scholar
• Akira S. Toll-like receptor signaling. J Biol Chem. 2003;278:38105–38108. doi:10.1074/jbc.R30002820012893815
   PubMed Web of Science ®Google Scholar
• Gilmore TD. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene. 2006;25(51):6680–6684. doi:10.1038/sj.onc.120995417072321
   PubMed Web of Science ®Google Scholar
• Li D, Pan X, Zhao J, et al. Bone marrow mesenchymal stem cells suppress acute lung injury induced by lipopolysaccharide through inhibiting the TLR2, 4/NF-κB pathway in rats with multiple trauma. Shock. 2016;45(6):641–646. doi:10.1097/SHK.000000000000054826717106
   PubMed Web of Science ®Google Scholar
• Barabutis N, Dimitropoulou C, Birmpas C, Joshi A, Thangjam G, Catravas JD. p53 protects against LPS-induced lung endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol. 2015;308(8):L776–87. doi:10.1152/ajplung.00334.201425713322
   PubMed Web of Science ®Google Scholar
• Di A, Mehta D, Malik AB. ROS-activated calcium signaling mechanisms regulating endothelial barrier function. Cell Calcium. 2016;60(3):163–171. doi:10.1016/j.ceca.2016.02.00226905827
   PubMed Web of Science ®Google Scholar
• Brenner JS, Greineder C, Shuvaev V, Muzykantov V. Endothelial nanomedicine for the treatment of pulmonary disease. Expert Opin Drug Deliv. 2015;12(2):239–261. doi:10.1517/17425247.2015.96141825394760
   PubMed Web of Science ®Google Scholar
• Brenner JS, Bhamidipati K, Glassman PM, et al. Mechanisms that determine nanocarrier targeting to healthy versus inflamed lung regions. Nanomedicine. 2017;13(4):1495–1506. doi:10.1016/j.nano.2016.12.01928065731
   PubMedGoogle Scholar
• Muro S, Dziubla T, Qiu W, et al. Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to intercellular adhesion molecule 1. J Pharmacol Exp Ther. 2006;317(3):1161–1169. doi:10.1124/jpet.105.09897016505161
   PubMed Web of Science ®Google Scholar
• Danielyan K, Ding BS, Gottstein C, Cines DB, Muzykantov VR. Delivery of anti-platelet-endothelial cell adhesion molecule single-chain variable fragment-urokinase fusion protein to the cerebral vasculature lyses arterial clots and attenuates postischemic brain edema. J Pharmacol Exp Ther. 2007;321(3):947–952. doi:10.1124/jpet.107.12053517389242
   PubMed Web of Science ®Google Scholar